| Name | Title | Contact Details |
|---|---|---|
Weily Soong |
Chief Research Innovation Officer | Profile |
Assembly Biosciences (NASDAQ: ASMB) is a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV) and diseases associated with the microbiome. The HBV program is focused on advancing a new class of potent, oral core inhibitors that have the potential to increase cure rates for chronically infected patients. The microbiome program is developing novel oral live microbial biotherapeutic candidates with Assembly`s fully integrated platform, including a robust process for strain identification and selection, GMP banking and production, and targeted delivery to the lower gastrointestinal tract with the GEMICEL® technology. We pride ourselves on creating a culture and work environment that is scientifically driven, ambitious, and collaborative. We encourage diversity of thought that leads to great innovation and are looking to add to our dynamic team great people who are driven to transform the lives of patients. We believe our Microbiome platform represents a best in class approach to developing biopharmaceutical agents from live biotherapeutic products. ABI-M201, our lead program in mildly to moderately active ulcerative colitis (UC), is currently in a phase 1b clinical trial. This program is part of a broader collaboration we established with Allergan in 2017 for gastrointestinal programs such as UC, Crohn`s disease and Irritable Bowel Syndromes with potential total development and commercial milestones of up to $2.8 billion. Our internal pipeline comprises first in class or best in class live microbial biotherapeutic approaches in areas such as oncology, immune mediated and metabolic disorders, and other areas of high medical need. Assembly is headquartered in Carmel, Indiana, while the R&D headquarters is in South San Francisco. The Company also has a microbiome manufacturing facility in Groton, CT, and offices in China.
Tepha is a Lexington, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Advantia is transforming healthcare for all women - we`re setting a higher standard of care and convenience while reducing unnecessary costs. Compassion and value inspire everything we do. We take time to listen, answer questions completely, and offer helpful technology between visits so that our patients are empowered and at ease. Alongside coordinated care, Advantia is pioneering care models that align incentives with the best interests of women and their families.
Image Owl creates complete, convenient , accurate and insightful cloud-based solutions to analyze and manage your diagnostic medical imaging and radiotherapy quality assurance needs.
obé is a premium fitness network and community that gets you results AND brings the fun. With 22 live classes per day and 5,000+ on-demand workouts available 24/7—all taught by the best instructors in NYC—our motto is: get fit, not bored. From HIIT to Pilates to Dance, Sculpt, Strength, Yoga, Pre/Postnatal, Cardio Boxing, and more, obé classes are designed to meet you wherever you are in your fitness journey.